Hyperthermia inhibits the proliferation and invasive ability of mouse malignant melanoma through TGF-β1

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 725-734

  Jin, Hekun ^a,b   Xie, Xiaoxue ^b   Hu, Bingqiang ^a   Gao, Fuping ^d   Zhou, Jumei ^a   Zhang, Yingying ^b   Du, Lehui ^c   Wang, Xiaowen ^c   Zhao, Lingyun ^c   Zhang, Xiaodong ^c   Shen, Liangfang ^c   Liao, Yuping ^b   Tang, Jintian ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c TSINGHUA UNIVERSITY   (China)

^d TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

Author keywords

Invasiveness; Malignant melanoma; MMP 2; MMP 9; Proliferation; TGF 1

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HYPERTHERMIC THERAPY; IN VIVO STUDY; MAGNETIC FLUID HYPERTHERMIA; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; FEMALE; HYPERTHERMIA, INDUCED; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SMAD4 PROTEIN; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84872778027     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2128     Document Type: Article

References (45)

1. Kim CJ, Reintgen DS and Balch CM: The new melanoma staging system. Cancer Control 9: 9-15, 2002. (Pubitemid 34203254)
2. Hofmann UB, Westphal JR, Van Muijen GNP and Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest Dermatol 115: 337-344, 2000.
3. Vihinen P and Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002. (Pubitemid 34309470)
4. Krasagakis K, Tholke D, Farthmann B, Eberle J, Mansmann U and Orfanos CE: Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer 77: 1492-1494, 1998. (Pubitemid 28190751)
5. Krasagakis K, Garbe C, Schrier PI and Orfanos CE: Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res 14: 2565-2571, 1994.
6. Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B and Herlyn M: Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97: 20-26, 1991.
7. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C and Kari C: Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54: 575-581, 1994. (Pubitemid 24053203)
8. Van Belle P, Rodeck U, Nuamah I, Halpern AC and Elder DE: Melanoma-associated expression of transforming growth factor-beta isoforms. Am J Pathol 148: 1887-1894, 1996.
9. Nagashima K, Takagi R and Hoshina H: Effect of local hyperthermia on metastases in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31: 84-89, 2002.
10. Sato T, Sawaji Y, Matsui N, Sato H, Motoharu S, Mori Y and Ito A: Heat shock suppresses membrane type 1-matrix metallo-proteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun 265: 189-193, 1999.
11. Nathanson SD, Cerra SD, Hetzel F W, et al: Changes associated with metastasis in B16-F1 melanoma cells surviving heat. Archives Sur 125: 216-219, 1990. (Pubitemid 20060647)
12. Jordan A, Scholz R, Wust P, Fakhling H and Felix R: Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201: 413-419, 1999.
13. Du LH, Zhou JM, Wang XW, Sheng L, Wang GH, Xie XX, Zhao LY, Liao YP and Tang JT: Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit VX2 liver tumor model. Prog Nat Sci 19: 1705-1712, 2009.
14. Wilhelm C, Fortin JP and Gazeau F: Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J Nanosci Nanotechnol 7: 2933-2937, 2007.
15. Gao F P, Cai YY, Zhou J, Xie XX, Ouyang WW, Zhang YH, Wang XF, Wang XW, Zhao LY and Tang JT: Pullulan acetate coated magnetite nanoparticles for hyperthermia: preparation, characterization and in vitro experiments. Nano Res 3: 23-31, 2010.
16. Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Buck W and Deimling AV: Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30: 52-57, 2009.
17. Suzuki M, Shinkai M, Honda H and Kobayashi T: Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 13:129-135, 2003. (Pubitemid 36583974)
18. Hilger I, Hergt R and Kaiser WA: Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 152: 33-39, 2005. (Pubitemid 40453794)
19. Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofiner N, Scholz R, Deger S, Wust P, Loening SA and Jordon A: Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 21: 637-647, 2005. (Pubitemid 41684238)
20. Jordan A and Maier-Hauff K: Magnetic nanoparticles for intra-cranial thermotherapy. J Nanosci Nanotechnol 7: 4604-4606, 2007.
21. Johannsen M, Thiesen B, Jordan A, Taymoor ian K, Gneveckow U, Waldofiner N, Scholz R, Koch M, Lein M, Jung K and Loening SA: Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 64: 283-392, 2005.
22. Ito A, Tannka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T and Kobayashi T: Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 94: 308-313, 2003. (Pubitemid 36575900)
23. Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefiner N, Teichgraeber U, Pinkemelle J, Brugn H, Neuman F, Thiesen B, et al: The effect of thermo therapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78: 7-14, 2006. (Pubitemid 43786652)
24. Xie XX, Shao XF, Gao FP, Jin HK, Zhou JM, Du LH, Zhang YY, Ouyang WW, Wang XW, Zhao LY, et al: Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells. Oncol Rep 25: 1573-1579, 2011.
25. Houghton AN and Polsky D: Focus on melanoma. Cancer Cell 2: 275-278, 2002. (Pubitemid 41043961)
26. Chiang WC, Wong YK, Lin SC, Chang KW and Liu CJ: Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression. Oral Dis 12: 27-33, 2006.
27. Puente XS, Sanchez LM, Overall CM and Lopez-Otin C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4: 544-558, 2003. (Pubitemid 36781345)
28. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149, 2000. (Pubitemid 30123793)
29. Ispanovic E and Haas TL: JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 291: 579-588, 2006.
30. Sawaji Y, Sato T, Seiki Mand Ito A: Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation. Clin Exp Metastasis 18: 131-138, 2000. (Pubitemid 32165246)
31. Welm AL: TGFbeta primes breast tumor cells for metastasis. Cell 133: 27-28, 2008. (Pubitemid 351442997)
32. Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T and Okumura K: Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91: 964-971, 2001.
33. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M and Kaibara N: The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86: 1455-1462, 1999. (Pubitemid 29489778)
34. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y and Matsuzawa Y: High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110: 375-382, 1996. (Pubitemid 26043869)
35. Oft M, Heider KH and Beug H: TGF-beta signaling is necessary for carcinoma invasiveness and metastasis. Curr Biol 8: 1243-1252, 1998. (Pubitemid 28540052)
36. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR and Guise TA: TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103: 197-206, 1999. (Pubitemid 29053137)
37. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ: TGF beta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542, 1996. (Pubitemid 26299485)
38. Padua D, Zhang XHF, Wang QQ, Nadal C, Gerald WL, Gomis RR and Massague J: TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77, 2008. (Pubitemid 351442989)
39. Krasagakis K, Kruger-Krasagakes S, Fimmel S, Eberle J, Tholke D, von der Ohe M, Mansmann U and Orfanos CE: Desensitization of melanoma cells to autocrine TGF-beta isoforms. J Cell Physiol 178: 179-187, 1999. (Pubitemid 29034861)
40. Janji B, Melchior C, Gouon V, Vallar L and Kieffer N: Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 83: 255-262, 1999. (Pubitemid 29449106)
41. Miyoshi E, Nishikawa A, Ihara Y, Saito H, Uozumi N, Hayashi N, Fusamoto H, Kamada T and Taniguchi N: Transforming growth factor beta up-regulates expression of the N-acetyl glucoseminyl transferase V gene in mouse melanoma cells. J Biol Chem 270: 6216-6220, 1995.
42. Park SS, Li L, Korn TS, Mitra MM and Niederkorn JY: Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells. Curr Eye Res 15: 755-763, 1996. (Pubitemid 26258402)
43. Rodeck U, Nishiyama T and Mauviel A: Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells. Cancer Res 59: 547-550, 1999. (Pubitemid 29076048)
44. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H and Kaiser W: Thermal ablation of tumors using magnetic nano-particles: an in vivo feasibility study. Invest Radiol 37: 580-586, 2002.
45. Brusentsova NA, Nikitinb L, Brusentsovac T, Brusentsava TN, Kuznetsov AA, Beyburtskiy FS, Shumakov LI and Jurchenko NY: Magnetic fluid hyperthermia of the mouse experimental tumor. J Magn Magn Mater 252: 378-380, 2002.